Brief: Geneuro Confirms Potential Of Novel PHERV-K Antibodies For ALS

Geneuro SA

17/10/2018 06:36

Oct 17 (Reuters) - GENEURO SA  GNRO.PA :
    * GENEURO CONFIRMS POTENTIAL OF NOVEL PHERV-K ANTIBODIES FOR
ALS
IN COLLABORATION WITH NINDS, SECURES RIGHTS
    * GENEURO LAUNCHES PHERV-K ENV ANTIBODY DEVELOPMENT PROGRAM,
AIMING TO REACH IND BY MID-2020
    * EXERCISES OPTION WITH NATIONAL INSTITUTE OF NEUROLOGICAL
DISORDERS AND STROKE (NINDS) TO SECURE WORLDWIDE DEVELOPMENT
RIGHTS

Source text for Eikon:  ID:nBw62yqMFa 
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))